- Clinical Trials
- April 2025
- 60 Pages
Global
From €1157EUR$1,250USD£980GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1157EUR$1,250USD£980GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1851EUR$2,000USD£1,567GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1388EUR$1,500USD£1,175GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1851EUR$2,000USD£1,567GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1157EUR$1,250USD£980GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1388EUR$1,500USD£1,175GBP
- Report
- June 2024
- 200 Pages
Global
From €7358EUR$7,950USD£6,230GBP
- Report
- July 2025
- 350 Pages
Global
From €4580EUR$4,949USD£3,878GBP
- Report
- June 2025
- 200 Pages
Global
From €2581EUR$2,789USD£2,186GBP
- Report
- July 2024
- 162 Pages
Africa
From €2314EUR$2,500USD£1,959GBP
- Report
- July 2024
- 164 Pages
Global
From €2314EUR$2,500USD£1,959GBP
- Report
- May 2024
- 134 Pages
Global
From €3701EUR$3,999USD£3,134GBP
- Report
- December 2023
- 221 Pages
Global
From €3331EUR$3,599USD£2,820GBP
- Report
- May 2025
- 134 Pages
Global
From €16654EUR$17,995USD£14,102GBP
- Report
- December 2024
- 59 Pages
Global
From €3697EUR$3,995USD£3,131GBP
- Report
- March 2024
- 95 Pages
Europe
From €1388EUR$1,500USD£1,175GBP
- Report
- March 2024
- 97 Pages
Asia Pacific
From €1388EUR$1,500USD£1,175GBP
- Report
- March 2024
- 91 Pages
North America
From €1388EUR$1,500USD£1,175GBP
- Report
- March 2024
- 97 Pages
Middle East, Africa
From €1388EUR$1,500USD£1,175GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more